[HTML][HTML] Endocrine therapy for breast cancer: a model of hormonal manipulation
SJ Johnston, KL Cheung - Oncology and Therapy, 2018 - Springer
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
SJ Johnston, KL Cheung - Oncology and Therapy, 2018 - go.gale.com
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation.
SJ Johnston, KL Cheung - Oncology & Therapy, 2018 - search.ebscohost.com
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
SJ Johnston, C Kwok-Leung - Oncology and Therapy, 2018 - search.proquest.com
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapy for breast cancer: a model of hormonal manipulation
SJ Johnston, KL Cheung - Oncology and Therapy - eprints.nottingham.ac.uk
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation.
SJ Johnston, KL Cheung - Oncology and Therapy, 2018 - europepmc.org
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
[HTML][HTML] Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
SJ Johnston, KL Cheung - Oncology and Therapy, 2018 - ncbi.nlm.nih.gov
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
SJ Johnston, KL Cheung - Oncology and therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
SJ Johnston, KL Cheung - 2018 - hero.epa.gov
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapy for breast cancer: a model of hormonal manipulation
SJ Johnston, KL Cheung - Oncology and Therapy - nottingham-repository.worktribe.com
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer.
Endocrine therapies targeting the ER represent one of the most successful anticancer …
Endocrine therapies targeting the ER represent one of the most successful anticancer …